The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Lymphoma incidence, survival and prevalence 2004–2014: sub-type analyses from the UK’s Haematological Malignancy Research Network
Open accessAbstract
BACKGROUND: Population-based information about cancer occurrence and survival are required to inform clinical practice and research; but for most lymphomas data are lacking. METHODS: Set within a socio-demographically representative UK population of nearly 4 million, lymphoma data (N=5796) are from an established patient cohort. RESULTS: Incidence, survival (overall and relative) and prevalence estimates for >20 subtypes are presented. With few exceptions, males tended to be diagnosed at younger ages and have significantly (P<0.05) higher incidence rates. Differences were greatest at younger ages: the <15 year male/female rate ratio for all subtypes combined being 2.2 (95% CI 1.3-3.4). These gender differences impacted on prevalence; most subtype estimates being significantly (P<0.05) higher in males than females. Outcome varied widely by subtype; survival of patients with nodular lymphocyte predominant Hodgkin lymphoma approached that of the general population, whereas less than a third of those with other B-cell (e.g., mantle cell) or T-cell (e.g., peripheral-T) lymphomas survived for ≥5 years. No males/female survival differences were detected. CONCLUSIONS: Major strengths of our study include completeness of ascertainment, world-class diagnostics and generalisability. The marked variations demonstrated confirm the requirement for 'real-world' data to inform aetiological hypotheses, health-care planning and the future monitoring of therapeutic changes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues
Swerdlow, S. H. (2017) · Medical Entomology and Zoology · Cited by 12,933
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
Ferlay, J., Steliarova-Foucher, E., Lortet-Tieulent, J., Rosso, S., Coebergh, J. W. W., Comber, H., Forman, D., & Bray, F. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2012.12.027 · Cited by 5,263
A Predictive Model for Aggressive Non-Hodgkin's Lymphoma
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291402 · Cited by 4,949
International Classification of Diseases for Oncology
National Cancer Institute (2020) · Definitions · doi:10.32388/1bjeus · Cited by 3,805
WHO classification of haematolymphoid tumours
Gaillard, F., Weerakkody, Y., & Sharma, R. (2010) · Radiopaedia.org · doi:10.53347/rid-9250 · Cited by 3,776
International Statistical Classification of Diseases and Related Health Problems
Eisfeld, J. (2014) · TSQ: Transgender Studies Quarterly · doi:10.1215/23289252-2399740 · Cited by 3,570
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
Rothwell, P. M. (2005) · The Lancet · doi:10.1016/s0140-6736(04)17670-8 · Cited by 2,544
Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues
Jaffe, E. S. (2003) · Cited by 2,141
Participation in Cancer Clinical Trials: Race-, Sex-, and Age-Based Disparities
Murthy, V. H., Krumholz, H. M., & Gross, C. P. (2004) · JAMA · doi:10.1001/jama.291.22.2720 · Cited by 2,078
Campo, E., Swerdlow, S. H., Harris, N. L., Pileri, S., Stein, H., & Jaffe, E. S. (2011) · Blood · doi:10.1182/blood-2011-01-293050 · Cited by 2,008
A Prognostic Score for Advanced Hodgkin's Disease
Hasenclever, D., Diehl, V., Armitage, J. O., Assouline, D., Björkholm, M., Brusamolino, E., Canellos, G. P., Carde, P., Crowther, D., Cunningham, D., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811193392104 · Cited by 1,736
Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001
Morton, L. M., Wang, S. S., Devesa, S. S., Hartge, P., Weisenburger, D. D., & Linet, M. S. (2006) · Blood · doi:10.1182/blood-2005-06-2508 · Cited by 1,683
Follicular lymphoma international prognostic index
Solal-Celigny, P. (2006) · Current Treatment Options in Oncology · doi:10.1007/s11864-006-0036-3 · Cited by 1,339
Pathology and genetics: Tumours of haematopoietic and lymphoid tissues
Vyas, P. (2001) · The Lancet Oncology · Cited by 1,007
Sehn, L. H., Donaldson, J., Chhanabhai, M., Fitzgerald, C., Gill, K., Klasa, R., MacPherson, N., O'Reilly, S., Spinelli, J. J., Sutherland, J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.137 · Cited by 987
Sant, M., Allemani, C., Tereanu, C., De Angelis, R., Capocaccia, R., Visser, O., Marcos-Gragera, R., Maynadié, M., Simonetti, A., Lutz, J.-M., et al. (2010) · Blood · doi:10.1182/blood-2010-05-282632 · Cited by 977
Wilkinson, E. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00737-4 · Cited by 951
Dreyling, M., Campo, E., Hermine, O., Jerkeman, M., Le Gouill, S., Rule, S., Shpilberg, O., Walewski, J., & Ladetto, M. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx223 · Cited by 741
Smith, A., Howell, D., Patmore, R., Jack, A., & Roman, E. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.450 · Cited by 692
Self-citationCancer Registration: Principles and Methods
Jensen, O. M. (1991) · Medical Entomology and Zoology · Cited by 673
Jaffe, E. S. (2009) · Hematology · doi:10.1182/asheducation-2009.1.523 · Cited by 632
Follicular Lymphoma International Prognostic Index
Solal-Celigny, P. (2004) · Blood · doi:10.1182/blood-2003-12-4434 · Cited by 626
Cunningham, D., Hawkes, E. A., Jack, A., Qian, W., Smith, P., Mouncey, P., Pocock, C., Ardeshna, K. M., Radford, J. A., McMillan, A., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60313-x · Cited by 561
Self-citationHarris, N. L., Jaffe, E. S., Diebold, J., Flandrin, G., Muller-Hermelink, H. K., & Vardiman, J. (2000) · Annals of Oncology · doi:10.1093/annonc/11.suppl_1.s3 · Cited by 329
Cancer Registration, Principles and Methods
Sanderson, H. F. (1992) · Journal of Epidemiology and Community Health · doi:10.1136/jech.46.4.461 · Cited by 328
Dreyling, M., Thieblemont, C., Gallamini, A., Arcaini, L., Campo, E., Hermine, O., Kluin-Nelemans, J. C., Ladetto, M., Le Gouill, S., Iannitto, E., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mds643 · Cited by 311
Sant, M., Minicozzi, P., Mounier, M., Anderson, L. A., Brenner, H., Holleczek, B., Marcos-Gragera, R., Maynadié, M., Monnereau, A., Osca-Gelis, G., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70282-7 · Cited by 291
Patient Income Level and Cancer Clinical Trial Participation
Unger, J. M., Hershman, D. L., Albain, K. S., Moinpour, C. M., Petersen, J. A., Burg, K., & Crowley, J. J. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.4553 · Cited by 290
Inclusion of minorities and women in cancer clinical trials, a decade later: have we improved?
Kwiatkowski, K., Coe, K., Bailar, J. C., & Swanson, G. M. (2013) · Cancer · doi:10.1002/cncr.28168 · Cited by 240
Freemantle, N., Marston, L., Walters, K., Wood, J., Reynolds, M. R., & Petersen, I. (2013) · BMJ · doi:10.1136/bmj.f6409 · Cited by 211
Olszewski, A. J., & Castillo, J. J. (2013) · Cancer · doi:10.1002/cncr.27773 · Cited by 205
Elting, L. S., Cooksley, C., Bekele, B. N., Frumovitz, M., Avritscher, E. B. C., Sun, C., & Bodurka, D. C. (2006) · Cancer · doi:10.1002/cncr.21907 · Cited by 176
Smith, A. G., Roman, E., Howell, D. A., Jones, R., Patmore, R. D., & Jack, A. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.08010.x · Cited by 150
Self-citationComparative Effectiveness Research in Oncology Methodology: Observational Data
Hershman, D. L., & Wright, J. D. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.41.6701 · Cited by 132
Dreyling, M. H., Ghielmini, M. E. G., Marcus, R. E., Salles, G., & Vitolo, U. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr388 · Cited by 130
Methods in Comparative Effectiveness Research
Armstrong, K. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.2659 · Cited by 127
Cancer survival in England and Wales at the end of the 20th century
Rachet, B., Woods, L. M., Mitry, E., Riga, M., Cooper, N. S., Quinn, M. J., Steward, J., Brenner, H., Estève, J., Sullivan, R. J., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604571 · Cited by 120
Racial differences in three major NHL subtypes: Descriptive epidemiology
Li, Y., Wang, Y., Wang, Z., Yi, D., & Ma, S. (2015) · Cancer Epidemiology · doi:10.1016/j.canep.2014.12.001 · Cited by 114
Cancer Trials Versus the Real World in the United States
Al‐Refaie, W. B., Vickers, S. M., Zhong, W., Parsons, H. M., Rothenberger, D. A., & Habermann, E. B. (2011) · Annals of Surgery · doi:10.1097/sla.0b013e31822a7047 · Cited by 93
Marcos‐Gragera, R., Allemani, C., Ţereanu, C., Angelis, R. D., Capocaccia, R., Maynadié, M., Luminari, S., Ferretti, S., Johannesen, T. B., Sankila, R. J., et al. (2011) · Haematologica · doi:10.3324/haematol.2010.034264 · Cited by 74
Tripathy, D., Kaufman, P. A., Brufsky, A., Mayer, M., Yood, M. U., Yoo, B., Quah, C. S., Yardley, D. A., & Rugo, H. S. (2013) · The Oncologist · doi:10.1634/theoncologist.2012-0414 · Cited by 74
van de Water, W., Kiderlen, M., Bastiaannet, E., Siesling, S., Westendorp, R. G. J., van de Velde, C. J. �., Nortier, J. W. R., Seynaeve, C., de Craen, A. J. M., & Liefers, G. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju051 · Cited by 73
Penberthy, L. T., Brown, R., Wilson-Genderson, M., Dahman, B. A., Ginder, G. D., & Siminoff, L. A. (2012) · Clinical Trials · doi:10.1177/1740774512458992 · Cited by 64
Commentary: External validity of results of randomized trials: disentangling a complex concept
Rothwell, P. M. (2009) · International Journal of Epidemiology · doi:10.1093/ije/dyp305 · Cited by 64
Effect of Patient Socioeconomic Status on Access to Early-Phase Cancer Trials
Noor, A. M., Sarker, D., Vizor, S., McLennan, B. K., Hunter, S., Suder, A., Møller, H., Spicer, J. F., & Papa, S. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.0999 · Cited by 61
Smith, A. G., Painter, D., Howell, D. A., Evans, P., Smith, G., Patmore, R. D., Jack, A., & Roman, E. (2014) · BMJ Open · doi:10.1136/bmjopen-2013-004266 · Cited by 56
Self-citationCancer registration: principles and methods. Reporting of results.
Jensen, O. M., & Storm, H. H. (1991) · PubMed · Cited by 50
Nabhan, C., Aschebrook‐Kilfoy, B., Chiu, B. C. ‐., Kruczek, K. R., Smith, S. M., & Evens, A. M. (2014) · American Journal of Hematology · doi:10.1002/ajh.23708 · Cited by 48
Press, O. W., Unger, J. M., Rimsza, L. M., Friedberg, J. W., LeBlanc, M. L., Czuczman, M. S., Kaminski, M. S., Braziel, R. M., Spier, C. M., Gopal, A. K., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1120 · Cited by 42
Control of data quality for population-based cancer survival analysis
Li, R., Abela, L., Moore, J., Woods, L. M., Nur, U., Rachet, B., Allemani, C., & Coleman, M. P. (2014) · Cancer Epidemiology · doi:10.1016/j.canep.2014.02.013 · Cited by 26
Puvvada, S. D., Kendrick, S. L., & Rimsza, L. M. (2013) · Cancer Genetics · doi:10.1016/j.cancergen.2013.07.003 · Cited by 25
Appropriate management of molecular subtypes of diffuse large B-cell lymphoma.
Dunleavy, K. M., & Wilson, W. H. (2014) · PubMed · Cited by 20
Analysis of patient selection and external validity in the Swedish contribution to the COLOR trial
Janson, M., Edlund, G., Kressner, U., Lindholm, E., Påhlman, L., Skullman, S., Anderberg, B., & Haglind, E. (2008) · Surgical Endoscopy · doi:10.1007/s00464-008-0203-7 · Cited by 18
Cited by
2016 US lymphoid malignancy statistics by World Health Organization subtypes
Teras, L. R., DeSantis, C. E., Cerhan, J. R., Morton, L. M., Jemal, A., & Flowers, C. R. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21357 · Cited by 1,125
Lacy, S. E., Barrans, S. L., Beer, P. A., Painter, D., Smith, A. G., Roman, E., Cooke, S. L., Ruiz, C., Glover, P., Van Hoppe, S. J. L., et al. (2020) · Blood · doi:10.1182/blood.2019003535 · Cited by 506
Self-citationMeignan, M., Cottereau, A. S., Versari, A., Chartier, L., Dupuis, J., Boussetta, S., Grassi, I., Casasnovas, R.-O., Haioun, C., Tilly, H., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.66.9440 · Cited by 326
Sha, C., Barrans, S., Cucco, F., Bentley, M. A., Care, M. A., Cummin, T., Kennedy, H., Thompson, J. S., Uddin, R., Worrillow, L., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.01314 · Cited by 300
Carbone, A., Roulland, S., Gloghini, A., Younes, A., von Keudell, G., López-Guillermo, A., & Fitzgibbon, J. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0132-x · Cited by 278
Metadata
- Authors
- Smith, A., Crouch, S., Lax, S., Li, J., Painter, D., Howell, D., Patmore, R., Jack, A., & Roman, E.
- Venue
- British Journal of Cancer
- Published
- 2015-03-24
- Volume
- 112
- Issue
- 9
- Pages
- 1575-1584
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2035098923
- Cited by
- 424
- References
- 53
- FWCI
- 20.42
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.